FOSAR-NVpEc https://histock.tw/talk/live.aspx?name=gtalk&id=1278 20240529 紫殺

台股 » 個股 » 中化生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中化生

(1762)
可現股當沖
  • 股價
    47.50
  • 漲跌
    ▲0.55
  • 漲幅
    +1.17%
  • 成交量
    236
  • 產業
    上市 生技醫療類股
  • 251人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
中化生 (1762)籌碼相關-富邦-中和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-中和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/12/120.257.0000.0056.600.24900.04%
2023/12/0500.00559.3059.20-5492-1.01%
2023/12/04160.4000.0060.3014870.21%
2023/11/27162.90261.7061.30-1438-0.23%
2023/11/24158.30157.7057.9003840.00%
2023/11/20157.3000.0057.6013770.26%
2023/10/2500.00354.5054.00-3540-0.55%
2023/10/12157.0000.0057.2016470.15%
2023/10/03658.5000.0058.3068380.72%
2023/09/260.159.6000.0059.200.19750.01%
2023/09/21160.3000.0059.7011,0770.09%
2023/09/1800.00162.6062.40-11,203-0.08%
2023/09/14261.7000.0061.6021,2100.17%
2023/09/12060.8000.0060.5001,2290.00%
2023/09/08160.2000.0060.2011,2460.08%
2023/09/07161.0000.0060.8011,2630.08%
2023/09/011.262.48162.6062.600.21,4150.01%
2023/08/31161.8000.0061.9011,4290.07%
2023/08/240.162.7000.0062.400.11,5730.00%
2023/08/1800.00763.1063.60-71,653-0.42%
2023/08/1700.00265.0065.50-21,660-0.12%
2023/08/110.168.0000.0067.500.11,8720.01%
2023/08/1000.00370.0068.40-31,928-0.16%
2023/08/0200.00373.0372.80-32,342-0.13%
2023/07/31274.101.374.4073.600.82,4350.03%
2023/07/28276.20176.5076.2012,4940.04%
2023/07/27177.30277.6577.30-12,506-0.04%
2023/07/26176.20176.1076.1002,5350.00%
2023/07/2100.00180.8078.60-12,668-0.04%
2023/07/18178.80678.1778.00-52,749-0.18%
2023/07/17280.756080.4680.30-582,781-2.09%
2023/07/14580.4800.0080.3052,8150.18%
2023/07/1314.378.83479.1578.5010.32,8580.36%
2023/07/1200.00379.3078.40-32,936-0.10%
2023/07/11481.38581.3081.30-12,978-0.03%
2023/07/1000.00190.2090.30-12,984-0.03%
2023/07/071.590.4100.0089.901.53,0330.05%
2023/07/0600.00592.6091.60-53,101-0.16%
2023/07/054.593.2100.0093.204.53,1160.14%
2023/07/04194.7000.0094.8013,1420.03%
2023/07/03392.5000.0092.9033,1730.09%
2023/06/30593.28593.6692.4003,1970.00%
2023/06/29191.60292.4091.80-13,324-0.03%
2023/06/28391.33192.0091.8023,4260.06%
2023/06/27189.20589.1089.30-43,426-0.12%
2023/06/26186.20185.0085.0003,4580.00%
2023/06/16587.1000.0086.6053,5230.14%
2023/06/15385.0000.0085.7033,5280.09%
2023/06/13584.38484.2084.3013,6250.03%
2023/06/12586.8400.0084.0053,7070.13%
2023/06/094291.35188.7092.80413,8771.06%
2023/06/081187.9500.0087.70113,9550.28%
2023/06/0700.00190.2089.50-13,957-0.03%
2023/06/06390.4000.0090.4033,9750.08%
2023/05/30188.8000.0089.0014,2660.02%
2023/05/22093.3000.0095.4004,2180.00%
2023/05/1700.00198.7098.50-14,100-0.02%
2023/05/16495.98493.2596.6004,0340.00%
2023/05/12796.99593.5093.8024,0280.05%
2023/05/11796.99593.5094.9023,9510.05%
2023/05/1000.001100.00102.50-13,756-0.03%
2023/05/09293.20295.9093.2003,6390.00%
2023/04/1800.00695.3094.40-63,086-0.19%
2023/04/14890.258.291.5691.50-0.22,955-0.01%
2023/04/1300.00187.7088.00-12,870-0.03%
2023/04/12684.30683.6084.0002,7950.00%
2023/04/10181.6000.0082.7012,7970.04%
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章